Sixth Street, KKR Provide BridgeBio $1 Billion Preferred Equity

Sixth Street Partners and KKR & Co. have agreed to provide $1 billion of preferred equity to biotechnology company BridgeBio Pharma Inc., according to people with knowledge of the matter.

To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Bloomberg.